ExploreWatchlistsPricing
  1. JP-listed companies
  2. ONO PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Net income margin (%)

ONO PHARMACEUTICAL CO., LTD. (4528)

Market cap
¥1.2T
P/E ratio
16.9x
Japanese pharmaceutical company that develops, manufactures and sells prescription and over-the-counter drugs through a global network of 26 subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 202510.3-59.62%
Mar 31, 202425.5+1.00%
Mar 31, 202325.2+13.13%
Mar 31, 202222.3-8.63%
Mar 31, 202124.4+19.44%
Mar 31, 202020.4+14.34%
Mar 31, 201917.9-7.02%
Mar 31, 201819.2-15.74%
Mar 31, 201722.8+46.25%
Mar 31, 201615.6+63.07%
Mar 31, 20159.6-32.71%
Mar 31, 201414.2-11.54%
Mar 31, 201316.1-2.12%
Mar 31, 201216.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat